The Metabolic Triad Persists: Obesity, Diabetes, and Heart Disease
Allopathic medicine’s fault keeps trying to treat lifestyle with drugs and it’s just not working. The article “The Metabolic TRIAD Persists: Obesity, Diabetes, and Heart Disease” is another nail in the coffin of allopathic medicine and literally the coffins of millions of patients who have not been given any other options by a system that’s based on drugs. Short-term use of these drugs may be useful but not lifelong prescriptions.
There is no end of data that draws links between the triad. This data is the reason doctors say they have to use a half-dozen drugs to try and “prevent” the triad and all their associated diseases. I’m sure you know the scenario, I call it the blood pressure spiral.
Fortunately there are some doctors, like cardiovascular researcher Dr. James DiNicolantonio why say, “Subclinical Magnesium Deficiency: A Principal Driver of Cardiovascular Disease and A Public Health Crisis.” However, as I discovered with the world-renowned magnesium researchers, Drs. Burton and Bella Altura, clinical research from the hallowed halls of academia doesn’t often reach the doctors, who continue to take their prescribing cues from Big Pharma. Ginney and I also saw this at the magnesium research conference held at the NIH, March 2019. Incredible magnesium breakthroughs are occurring every day and I seem to be one of the few people beating the drum to bring magnesium to public awareness.
Instead of the logical conclusion to explore magnesium here is the wish list that allopathic medicine puts forth.
- Let’s lower the cut off for hypertension to 130/80 from 140/90 so we can give more drugs.
- Let’s put everyone on statins.
- Let’s give 6 medications for any sign of heart disease.
- Let’s give meds for diabetes not diet.
- Let’s do surgery for obesity.
Let’s Lower Hypertension to 130/80 Instead of 140/90
Once allopathic medicine became convinced that they should give drugs as their only solution to try and “prevent” the Triad, they looked for excuses to prescribe more drugs. They did this with hypertension in 2018 when they lowered the cutoff range of high blood pressure from 140/90 to 130/80. Suddenly the hypertensive population in the U.S. doubled.
A Medscape article “When to Start Treating Hypertension” announced this new cutoff but my mind immediately went to the studies showing that people with magnesium deficiency are at risk for hypertension. I’ve already mentioned the paper that I’m asking everyone to print up for their doctors, friends, and family: “Subclinical Magnesium Deficiency: A Principal Driver of Cardiovascular Disease and A Public Health Crisis.” In this paper, hypertension is the first entry. The section begins:
Arterial hypertension is the most significant global risk factor for cardiovascular morbidity and mortality, exhibiting the highest prevalence worldwide.
But then here’s what happens when allopathic medicine treats hypertension.